Anupam Rasayan buys 43% of Bliss GVS Pharma in a ₹2,198 crore deal.
Anupam Rasayan is taking control of Bliss GVS Pharma at ₹299 per share, triggering a mandatory open offer for an additional 26% stake.
What's new
- Anupam Rasayan signed a deal to acquire 43.3% of Bliss GVS from promoters and public shareholders.
- The acquisition price is ₹299 per share, triggering a mandatory open offer for 26% of equity.
- Anupam Rasayan will become the new promoter, reclassifying the existing group as public shareholders.
Why this matters
This deal is a complete change of control for Bliss GVS Pharma. It follows prior denials of such a move, making the acquisition an unexpected shift in the company's ownership and governance structure.
What we're watching
- Regulatory approvals required to finalize the change of control.
- The response from public shareholders to the open offer.
- The strategic direction the new promoter group sets for the business.
The full read
Anupam Rasayan is taking control of Bliss GVS Pharma. It has signed a share purchase agreement to acquire a 43.3% stake from existing promoters and certain public shareholders at ₹299 per share, a transaction worth ₹1,370 crore. This deal triggers a mandatory open offer for an additional 26% of equity, valued at ₹829 crore. The total transaction value exceeds ₹2,198 crore. This is a fundamental change of control for the company, which currently has a market capitalization of ₹3,176 crore. The move is unexpected, as the company previously denied speculation regarding such a sale. Once completed, Anupam Rasayan will become the new promoter, and the current promoter group will be reclassified as public shareholders. The open offer is not conditional on any minimum acceptance level, though it remains subject to standard regulatory approvals.
Questions answered
- What is the total value of the transaction?
- The deal is valued at over ₹2,198 crore. This includes the ₹1,370 crore acquisition of a 43.3% stake and an ₹829 crore mandatory open offer for an additional 26%.
- At what price is the acquisition happening?
- The shares are being acquired at ₹299 per share. This price applies to both the initial stake purchase and the mandatory open offer.
- What happens to the existing promoter group?
- The existing promoter group will be reclassified as public shareholders. Anupam Rasayan will take over as the new promoter of the company.
- Is the open offer conditional?
- No, the open offer is not conditional on any minimum acceptance level. It remains subject to standard regulatory approvals and conditions precedent.